RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.99
+8.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.82x
- Price / sales
- 1.72x
- Price / cash flow
- 8.84x
Enterprise value
- Enterprise value
- -$35.1M
- EV / sales
- -0.29x
- EV / EBITDA
- 0.66x
- EV / EBIT
- 0.57x
- Market cap
- $209.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026